Sleep-disordered breathing (SDB) and type 2 diabetes| ResMed
SDB and type 2 diabetes
COVID-19 Update
Healthcare professionals > Diagnosis and treatment > Sleep apnea > Comorbidities > SDB and type 2 diabetes

SDB and type 2 diabetes

SDB is common among patients with type 2 diabetes1 and is independently associated with glucose intolerance2, insulin resistance2, 3, and metabolic syndrome4.

However, despite the number of type 2 diabetes patients with SDB, sleep apnoea largely goes undiagnosed.5

Screen your patients for type 2 diabetes and SDB

As a result of accumulated research, the International Diabetes Federation (IDF) recognises the association between type 2 diabetes and sleep apnoea, and recommends routinely screening OSA patients for type 2 diabetes, and considering the possibility of OSA in all type 2 diabetes patients.6

Use these helpful sleep and diagnosis resources to get your patients screened for SDB.

References
  1. Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Walter R, Ewy GA, Howard BV, Punjabi NM; Sleep Heart Health Study.  Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 2003;26(3):702-9.
  2. Aronsohn RS, et al. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med. 2010, 181(5):507-13.
  3. Punjabi NM, et al. Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med., 179(3):235-40 3. Coughlin SR et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004, 25:735-741.
  4. Coughlin SR et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004, 25:735-741.
  5. T. Young, L. Evans, L. Finn, et al., Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women, Sleep 20 (1997) 705–706.
  6. Sleep-disordered breathing and type 2 diabetes. A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Jonathan E. Shaw, Naresh M. Punjabi, John P. Wilding, K. George M.M. Alberti, Paul Z. Zimmet. Diabetes Research and Clinical Practice 81 (2008) 2–12